1. Home
  2. TCX vs MNPR Comparison

TCX vs MNPR Comparison

Compare TCX & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tucows Inc.

TCX

Tucows Inc.

N/A

Current Price

$21.85

Market Cap

233.3M

Sector

Technology

ML Signal

N/A

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$76.19

Market Cap

531.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCX
MNPR
Founded
1992
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.3M
531.6M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
TCX
MNPR
Price
$21.85
$76.19
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$97.83
AVG Volume (30 Days)
29.5K
163.6K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$384,728,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.03
N/A
52 Week Low
$13.27
$21.00
52 Week High
$23.38
$105.00

Technical Indicators

Market Signals
Indicator
TCX
MNPR
Relative Strength Index (RSI) 57.61 42.10
Support Level $20.25 $74.51
Resistance Level $22.26 $79.31
Average True Range (ATR) 0.85 6.38
MACD -0.07 -0.93
Stochastic Oscillator 68.42 6.10

Price Performance

Historical Comparison
TCX
MNPR

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: